✕
Login
Register
Back to News
RBC Capital Maintains Outperform on Rhythm Pharmaceuticals, Raises Price Target to $137
Benzinga Newsdesk
www.benzinga.com
Positive 93.6%
Neg 0%
Neu 0%
Pos 93.6%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment